non-Hodgkin's lymphoma	is a	cancer
non-Hodgkin's lymphoma	affects	lymphocytes
non-Hodgkin's lymphoma	may cause	lymphadenopathy
non-Hodgkin's lymphoma	may cause	fever
non-Hodgkin's lymphoma	may cause	weight loss
non-Hodgkin's lymphoma	may cause	night sweats
non-Hodgkin's lymphoma	is diagnosed via	biopsy
non-Hodgkin's lymphoma	is staged with	PET scan
non-Hodgkin's lymphoma	is treated with	chemotherapy
non-Hodgkin's lymphoma	is treated with	immunotherapy
non-Hodgkin's lymphoma	is treated with	radiation therapy
non-Hodgkin's lymphoma	is treated with	stem cell transplant
rituximab	treats	non-Hodgkin's lymphoma
CHOP regimen	treats	non-Hodgkin's lymphoma
cyclophosphamide	is in	CHOP regimen
doxorubicin	is in	CHOP regimen
vincristine	is in	CHOP regimen
prednisone	is in	CHOP regimen
non-Hodgkin's lymphoma	has subtype	diffuse large B-cell lymphoma
non-Hodgkin's lymphoma	has subtype	follicular lymphoma
non-Hodgkin's lymphoma	has subtype	mantle cell lymphoma
non-Hodgkin's lymphoma	has subtype	Burkitt lymphoma
non-Hodgkin's lymphoma	has risk factor	immunodeficiency
non-Hodgkin's lymphoma	has risk factor	Epstein-Barr virus
non-Hodgkin's lymphoma	has risk factor	Helicobacter pylori
non-Hodgkin's lymphoma	has risk factor	pesticides
non-Hodgkin's lymphoma	has risk factor	age
non-Hodgkin's lymphoma	may lead to	anemia
non-Hodgkin's lymphoma	may lead to	infection
non-Hodgkin's lymphoma	may lead to	organ dysfunction
non-Hodgkin's lymphoma	requires monitoring	LDH levels
non-Hodgkin's lymphoma	requires monitoring	CBC
non-Hodgkin's lymphoma	may recur	relapse
non-Hodgkin's lymphoma	has prognostic factor	IPI score
non-Hodgkin's lymphoma	can spread to	bone marrow
non-Hodgkin's lymphoma	can spread to	liver
non-Hodgkin's lymphoma	can spread to	spleen
non-Hodgkin's lymphoma	can spread to	CNS
non-Hodgkin's lymphoma	is differentiated from	Hodgkin lymphoma
Reed-Sternberg cells	absent in	non-Hodgkin's lymphoma
CD20	is a marker for	non-Hodgkin's lymphoma
ibrutinib	treats	mantle cell lymphoma
bendamustine	treats	follicular lymphoma
obinutuzumab	treats	follicular lymphoma
CAR-T therapy	treats	refractory non-Hodgkin's lymphoma
axicabtagene ciloleucel	is a	CAR-T therapy
tisagenlecleucel	is a	CAR-T therapy
non-Hodgkin's lymphoma	may cause	B symptoms
non-Hodgkin's lymphoma	has genetic mutation	BCL2
non-Hodgkin's lymphoma	has genetic mutation	MYC
non-Hodgkin's lymphoma	has genetic mutation	TP53
non-Hodgkin's lymphoma	may involve	extranodal sites
non-Hodgkin's lymphoma	requires evaluation	flow cytometry
non-Hodgkin's lymphoma	may present with	pleural effusion
non-Hodgkin's lymphoma	may present with	ascites
non-Hodgkin's lymphoma	may require	lymph node excision
non-Hodgkin's lymphoma	has association	autoimmune diseases
non-Hodgkin's lymphoma	is more common in	males
non-Hodgkin's lymphoma	has incidence increase with	age
non-Hodgkin's lymphoma	is classified by	WHO classification
non-Hodgkin's lymphoma	has histological grade	low-grade
non-Hodgkin's lymphoma	has histological grade	high-grade
non-Hodgkin's lymphoma	has treatment complication	neutropenia
non-Hodgkin's lymphoma	has treatment complication	cardiotoxicity
non-Hodgkin's lymphoma	has treatment complication	secondary cancers
non-Hodgkin's lymphoma	may respond to	targeted therapy
non-Hodgkin's lymphoma	may be refractory to	chemotherapy
non-Hodgkin's lymphoma	survival rate depends on	stage
Ann Arbor staging	is used for	non-Hodgkin's lymphoma
non-Hodgkin's lymphoma	stage I	involves single lymph node region
non-Hodgkin's lymphoma	stage II	involves multiple lymph node regions
non-Hodgkin's lymphoma	stage III	involves lymph nodes on both sides of diaphragm
non-Hodgkin's lymphoma	stage IV	involves extranodal spread
non-Hodgkin's lymphoma	has survival marker	Ki-67 index
non-Hodgkin's lymphoma	may co-occur with	HIV
non-Hodgkin's lymphoma	in HIV patients	is often aggressive
non-Hodgkin's lymphoma	may require	intrathecal chemotherapy
non-Hodgkin's lymphoma	can cause	hypercalcemia
non-Hodgkin's lymphoma	may lead to	superior vena cava syndrome
non-Hodgkin's lymphoma	may cause	spinal cord compression
non-Hodgkin's lymphoma	may require	surgical debulking
non-Hodgkin's lymphoma	has differential diagnosis	sarcoidosis
non-Hodgkin's lymphoma	has differential diagnosis	tuberculosis
non-Hodgkin's lymphoma	may mimic	metastatic carcinoma
non-Hodgkin's lymphoma	may be associated with	hepatitis C
non-Hodgkin's lymphoma	research involves	checkpoint inhibitors
pembrolizumab	is being studied for	non-Hodgkin's lymphoma
nivolumab	is being studied for	non-Hodgkin's lymphoma
non-Hodgkin's lymphoma	has experimental treatment	bispecific antibodies
non-Hodgkin's lymphoma	may affect	PFS
non-Hodgkin's lymphoma	may affect	OS
non-Hodgkin's lymphoma	prognosis depends on	molecular subtype
non-Hodgkin's lymphoma	has research focus	liquid biopsy
non-Hodgkin's lymphoma	has research focus	minimal residual disease
non-Hodgkin's lymphoma	requires supportive care	growth factors
non-Hodgkin's lymphoma	requires supportive care	antiemetics
non-Hodgkin's lymphoma	requires supportive care	transfusion support
non-Hodgkin's lymphoma	has palliative option	radiation therapy
non-Hodgkin's lymphoma	may benefit from	clinical trials
non-Hodgkin's lymphoma	research explores	tumor microenvironment
ENTITY	RELATIONSHIP	ENTITY
